speb/financial-data huggingface dataset:
Financial ratios for XGN — annual report dated 2023-12-31
Total revenue: 52548000
Gross profit: 29456000
Operating income: -22837000
Net income: -23689000
Capital expenditures: 804000
Operating cash flow: -14462000
Depreciation & amortization: 2168000
Net tangible assets: 22694000
Owner earnings: -22325000
Return on net tangible assets (%): -98.37401956464264
Buffett classification: The Gruesome
Stock price: 1.99
Shares outstanding: 24159839
Book value: 22694000
P/B ratio: 2.1185370410681235
Market cap (USD): 48078079.61
Debt to equity: 1.0236626421080461
Current ratio: 4.019576541757687
Quick ratio: 4.019576541757687
Interest coverage ratio: -9.780299785867237
COGS to revenue (%): 43.944583999391035
R&D to revenue (%): 9.258202024815407
SG&A to revenue (%): 90.25652736545634
Free cash flow (dilution-adjusted): -18907000
Buyback yield (%): 0
Retained earnings: -279216000
Receivables turnover: 8.021370783086551
Capitalized R&D asset: 11481920
ROCI (R&D-adjusted, %): -40.48846340923748
Rosenberg metric: 0.8208788983394086
FCF margin (%): -35.98043693385095
Revenue growth (%): 15.330421614028927
Rule of 40 score: -20.650015319822025
Financial ratios for XGN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.09
Shares outstanding: 24159839
Market cap (USD): 74653902.50999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XGN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.1
Shares outstanding: 24159839
Market cap (USD): 99055339.89999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XGN — annual report dated 2024-12-31
Total revenue: 55641000
Gross profit: 33112000
Operating income: -13636000
Net income: -15115000
Capital expenditures: 515000
Operating cash flow: -13279000
Depreciation & amortization: 1724000
Net tangible assets: 9540000
Owner earnings: -13906000
Return on net tangible assets (%): -145.76519916142558
Buffett classification: The Gruesome
Stock price: 4.1
Shares outstanding: 24159839
Book value: 9540000
P/B ratio: 10.38315931865828
Market cap (USD): 99055339.89999999
Debt to equity: 2.4324947589098533
Current ratio: 2.6991707389308455
Quick ratio: 2.6991707389308455
Interest coverage ratio: -6.103849597135183
COGS to revenue (%): 40.48992649305369
R&D to revenue (%): 9.66014270052659
SG&A to revenue (%): 74.35703887421147
Free cash flow (dilution-adjusted): -15557000
Buyback yield (%): 0
Retained earnings: -294331000
Receivables turnover: 7.1015954052329295
Capitalized R&D asset: 11893630
ROCI (R&D-adjusted, %): -34.743510189477064
Rosenberg metric: 0.7514902363823227
FCF margin (%): -27.959598138063658
Revenue growth (%): 5.886047042703814
Rule of 40 score: -22.073551095359843
Financial ratios for XGN — quarterly report dated 2025-03-31
Total revenue: 15498000
Gross profit: 9123000
Operating income: -3365000
Net income: -3752000
Capital expenditures: 107000
Operating cash flow: -10671000
Depreciation & amortization: 440000
Net tangible assets: 6403000
Owner earnings: -3419000
Return on net tangible assets (%): -53.39684522879901
Buffett classification: The Gruesome
Stock price: 3.59
Shares outstanding: 24159839
Book value: 6403000
P/B ratio: 13.545810090582538
Market cap (USD): 86733822.00999999
Debt to equity: 3.660159300327971
Current ratio: 2.322615219721329
Quick ratio: 2.322615219721329
Interest coverage ratio: -6.174311926605505
COGS to revenue (%): 41.13433991482772
R&D to revenue (%): 8.284939992257065
SG&A to revenue (%): 72.29319912246741
Free cash flow (dilution-adjusted): -11201000
Buyback yield (%): 0
Retained earnings: -298083000
Receivables turnover: 1.0522813688212929
Capitalized R&D asset: 1284000
ROCI (R&D-adjusted, %): -9.096182431207628
FCF margin (%): -72.27384178603691
Rule of 40 score: -72.27384178603691
Financial ratios for XGN — quarterly report dated 2025-06-30
Total revenue: 17202000
Gross profit: 10395000
Operating income: -2630000
Net income: -4439000
Capital expenditures: 209000
Operating cash flow: -2885000
Depreciation & amortization: 466000
Net tangible assets: 21034000
Owner earnings: -4182000
Return on net tangible assets (%): -19.882095654654368
Buffett classification: The Gruesome
Stock price: 6.98
Shares outstanding: 24159839
Book value: 21034000
P/B ratio: 8.017289922030999
Market cap (USD): 168635676.22
Debt to equity: 1.19825045164971
Current ratio: 4.952501214181641
Quick ratio: 4.952501214181641
Interest coverage ratio: -2.3398576512455516
COGS to revenue (%): 39.57098011859086
R&D to revenue (%): 8.621090570863853
SG&A to revenue (%): 67.09684920358097
Free cash flow (dilution-adjusted): -3537000
Buyback yield (%): 0
Retained earnings: -302522000
Receivables turnover: 1.1167229291093224
Capitalized R&D asset: 2343280
ROCI (R&D-adjusted, %): -4.072826974920886
Rosenberg metric: 0.9906542056074766
FCF margin (%): -20.561562608998955
Revenue growth (%): 10.994967092528068
Rule of 40 score: -9.566595516470887
Financial ratios for XGN — quarterly report dated 2025-09-30
Total revenue: 17244000
Gross profit: 10075000
Operating income: -3100000
Net income: -7087000
Capital expenditures: 275000
Operating cash flow: 2944000
Depreciation & amortization: 612000
Net tangible assets: 18138000
Owner earnings: -6750000
Return on net tangible assets (%): -37.21468739662587
Buffett classification: The Gruesome
Stock price: 10.99
Shares outstanding: 24159839
Book value: 18138000
P/B ratio: 14.638693935935605
Market cap (USD): 265516630.61
Debt to equity: 1.434888080273459
Current ratio: 4.079829325058185
Quick ratio: 4.079829325058185
Interest coverage ratio: -2.350265352539803
COGS to revenue (%): 41.57388077012294
R&D to revenue (%): 10.032475063790304
SG&A to revenue (%): 66.37091162143354
Free cash flow (dilution-adjusted): 2076000
Buyback yield (%): 0
Retained earnings: -309609000
Receivables turnover: 1.4077883908890523
Capitalized R&D asset: 3147330
ROCI (R&D-adjusted, %): -5.4050153795200595
Rosenberg metric: -0.2157788267026298
FCF margin (%): 12.038970076548365
Revenue growth (%): 0.24415765608650158
Rule of 40 score: 12.283127732634867
Financial ratios for XGN — quarterly report dated 2025-12-31
Total revenue: 16631000
Gross profit: 9206000
Operating income: -4975000
Net income: -4673000
Capital expenditures: 35000
Operating cash flow: -3013000
Depreciation & amortization: 600000
Net tangible assets: 17449000
Owner earnings: -4108000
Return on net tangible assets (%): -23.542896441056794
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 24159839
Book value: 17449000
P/B ratio: 8.418351832196688
Market cap (USD): 146891821.12
Debt to equity: 1.4732076336752822
Current ratio: 3.4531393459990114
Quick ratio: 3.4531393459990114
Interest coverage ratio: -3.7406015037593985
COGS to revenue (%): 44.64554145872167
R&D to revenue (%): 10.564608261679995
SG&A to revenue (%): 74.703866273826
Free cash flow (dilution-adjusted): -3762000
Buyback yield (%): 0
Retained earnings: -314282000
Receivables turnover: 1.5321050207277753
Capitalized R&D asset: 3405490
ROCI (R&D-adjusted, %): -10.312719248418274
Rosenberg metric: -0.5023121387283237
FCF margin (%): -22.620407672418978
Revenue growth (%): -3.5548596613314776
Rule of 40 score: -26.175267333750455
Financial ratios for XGN — annual report dated 2025-12-31
Total revenue: 66575000
Gross profit: 38799000
Operating income: -14070000
Net income: -19951000
Capital expenditures: 626000
Operating cash flow: -13625000
Depreciation & amortization: 2118000
Net tangible assets: 17449000
Owner earnings: -18459000
Return on net tangible assets (%): -105.78829732362887
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 24159839
Book value: 17449000
P/B ratio: 8.418351832196688
Market cap (USD): 146891821.12
Debt to equity: 1.4732076336752822
Current ratio: 3.4531393459990114
Quick ratio: 3.4531393459990114
Interest coverage ratio: -3.25845298749421
COGS to revenue (%): 41.721366879459254
R&D to revenue (%): 9.393916635373639
SG&A to revenue (%): 70.01877581674802
Free cash flow (dilution-adjusted): -16424000
Buyback yield (%): 0
Retained earnings: -314282000
Receivables turnover: 6.133118378627361
Capitalized R&D asset: 11460700
ROCI (R&D-adjusted, %): -24.06563552329291
Rosenberg metric: 1.058046511627907
FCF margin (%): -24.66992114156966
Revenue growth (%): 19.65097679768516
Rule of 40 score: -5.018944343884499
Financial ratios for 1CG.AX — annual report dated 2021-12-31
Capital expenditures: 0
Net tangible assets: 237473.18840579712
Buffett classification: The Gruesome
Shares outstanding: 1307286148
Book value: 190844.20289855075
Debt to equity: 0
Current ratio: 2.6220252759164366
Quick ratio: 2.6220252759164366
Retained earnings: -10716297.826086957
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1CG.AX — annual report dated 2022-12-31
Total revenue: 1094676.3513513515
Gross profit: 1094676.3513513515
Operating income: -4528608.783783784
Net income: -4667468.918918919
Capital expenditures: 8436.486486486487
Depreciation & amortization: 406641.8918918919
Net tangible assets: 1655707.4324324324
Owner earnings: -4269263.513513513
Return on net tangible assets (%): -257.85132263623734
Buffett classification: The Gruesome
Shares outstanding: 1307286148
Book value: 2149118.2432432435
Debt to equity: 0.0735814028066193
Current ratio: 4.495771716992827
Quick ratio: 4.482123230944729
Interest coverage ratio: -66.6329409659396
COGS to revenue (%): 0
SG&A to revenue (%): 272.61204564350436
Free cash flow (dilution-adjusted): -2109108.108108108
Retained earnings: -6888147.297297297
Inventory turnover: 0
Receivables turnover: 2.9785413958755798
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -196.2770463886656
FCF margin (%): -192.6695598662075
Rule of 40 score: -192.6695598662075
Financial ratios for 2559.HK — annual report dated 2022-12-31
Total revenue: 81764080.45977011
Gross profit: 61431465.51724138
Operating income: 5690086.206896552
Net income: -26958477.011494253
Capital expenditures: 326149.4252873563
Operating cash flow: 15429741.379310345
Depreciation & amortization: 1672988.5057471264
Net tangible assets: -534538793.1034483
Owner earnings: -25611637.93103448
Capex to operating income (%): 5.731888998308208
Buffett classification: The Great
Shares outstanding: 1026282344
Book value: -534538793.1034483
Debt to equity: -1.2016861135526113
Current ratio: 0.22889914886783364
Quick ratio: 0.22889914886783364
Interest coverage ratio: 172.18695652173915
COGS to revenue (%): 24.867417120324458
R&D to revenue (%): 15.638453779622477
SG&A to revenue (%): 39.021188659551065
Free cash flow (dilution-adjusted): 10818821.83908046
Receivables turnover: 28.317973726114648
Capitalized R&D asset: 12786637.931034483
FCF margin (%): 13.23175381933584
Rule of 40 score: 13.23175381933584
Financial ratios for 2559.HK — annual report dated 2023-12-31
Total revenue: 114639240.5063291
Gross profit: 85143600.5625879
Operating income: 15699156.11814346
Net income: 42248101.26582278
Capital expenditures: 300843.88185654004
Operating cash flow: 32379746.835443035
Depreciation & amortization: 1584106.8917018285
Net tangible assets: -465470042.1940928
Owner earnings: 43531364.27566807
Return on net tangible assets (%): -9.352130175869892
Capex to operating income (%): 1.91630607143817
Buffett classification: The Great
Shares outstanding: 1026282344
Book value: -465470042.19409287
Debt to equity: -1.2873957695017844
Current ratio: 0.3021955552933116
Quick ratio: 0.3021955552933116
Effective tax rate (%): 6.203571573546999
Interest coverage ratio: 391.65263157894736
COGS to revenue (%): 25.729095738481266
R&D to revenue (%): 14.930835434341205
SG&A to revenue (%): 32.588871099333204
Free cash flow (dilution-adjusted): 16552180.028129393
Receivables turnover: 68.55214465937762
Capitalized R&D asset: 25683643.756971724
Rosenberg metric: 1.8544464286264597
FCF margin (%): 14.438494144782446
Revenue growth (%): 40.20733782083485
Rule of 40 score: 54.6458319656173
Financial ratios for 2609.HK — annual report dated 2022-12-31
Total revenue: 115323563.21839081
Gross profit: 11430603.448275862
Operating income: -5571264.367816092
Net income: -8335919.540229885
Capital expenditures: 4229454.022988506
Operating cash flow: 16436063.218390804
Depreciation & amortization: 10710344.827586208
Net tangible assets: 9961494.252873564
Owner earnings: -1855028.735632183
Return on net tangible assets (%): -18.621992730629426
Buffett classification: The Gruesome
Shares outstanding: 1318466823
Book value: 156104885.05747125
Debt to equity: 0.4211819713020829
Current ratio: 0.8267089763516516
Quick ratio: 0.7514216215779393
Interest coverage ratio: -1.6418681458271585
COGS to revenue (%): 90.08823250923189
SG&A to revenue (%): 4.272710963157134
Free cash flow (dilution-adjusted): 11187787.35632184
Retained earnings: -38269683.90804598
Inventory turnover: 12.935972664496047
Receivables turnover: 5.387866339092728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.83349007555048
FCF margin (%): 9.701215470714581
Rule of 40 score: 9.701215470714581
Financial ratios for 2609.HK — annual report dated 2023-12-31
Total revenue: 150797890.29535866
Gross profit: 25058227.848101266
Operating income: 3031504.922644163
Net income: -3432630.0984528833
Capital expenditures: 6380872.011251758
Operating cash flow: 18054992.967651196
Depreciation & amortization: 12133755.274261603
Net tangible assets: 23942475.38677918
Owner earnings: 2320253.1645569624
Capex to operating income (%): 210.48529275308528
Buffett classification: The Gruesome
Shares outstanding: 1318466823
Book value: 165333052.03938115
Debt to equity: 0.4510921993538168
Current ratio: 0.9970002230115259
Quick ratio: 0.9158743411641201
Interest coverage ratio: 0.8085984393757503
COGS to revenue (%): 83.38290555721885
SG&A to revenue (%): 4.59729912989788
Free cash flow (dilution-adjusted): 10487060.478199719
Retained earnings: -41173839.66244726
Inventory turnover: 14.98531654905379
Receivables turnover: 6.28696661760653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.460280294684753
FCF margin (%): 6.954381429116382
Revenue growth (%): 30.760692860130696
Rule of 40 score: 37.71507428924708
Financial ratios for 2609.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 22331369.8630137
Buffett classification: The Gruesome
Shares outstanding: 1318466823
Book value: 160283013.69863012
Debt to equity: 0.44207591708501914
Current ratio: 0.9695806839069653
Quick ratio: 0.8893041842069245
Retained earnings: -41945616.43835617
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2609.HK — annual report dated 2024-12-31
Total revenue: 162855616.43835616
Gross profit: 28520136.98630137
Operating income: 4367945.205479452
Net income: -487260.27397260274
Capital expenditures: 6010136.98630137
Operating cash flow: 23087671.232876714
Depreciation & amortization: 11972054.794520548
Net tangible assets: 22331369.8630137
Owner earnings: 5474657.534246575
Capex to operating income (%): 137.5964373079094
Buffett classification: The Gruesome
Shares outstanding: 1318466823
Book value: 160283013.69863012
Debt to equity: 0.44207591708501914
Current ratio: 0.9695806839069653
Quick ratio: 0.8893041842069245
Effective tax rate (%): 126.72025240384615
Interest coverage ratio: 1.4830697674418605
COGS to revenue (%): 82.48747104334792
SG&A to revenue (%): 14.932968609895648
Free cash flow (dilution-adjusted): 16724109.589041097
Retained earnings: -41945616.43835617
Inventory turnover: 15.625880365849774
Receivables turnover: 5.222712296270263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2434185854910216
FCF margin (%): 10.269286349956177
Revenue growth (%): 7.995951481403864
Rule of 40 score: 18.26523783136004
Financial ratios for 3650.HK — annual report dated 2022-12-31
Total revenue: 317751580.45977014
Gross profit: 129364942.52873564
Operating income: -103931752.87356322
Net income: -15021695.402298851
Capital expenditures: 1859626.4367816092
Operating cash flow: -65514798.85057471
Depreciation & amortization: 8186925.287356322
Net tangible assets: -1086388074.7126436
Owner earnings: -8694396.551724138
Buffett classification: The Gruesome
Shares outstanding: 495166487
Book value: -1079046408.045977
Debt to equity: -0.023720790081387045
Current ratio: 3.641351191323835
Quick ratio: 3.3899147823088978
Interest coverage ratio: -98.91494598659921
COGS to revenue (%): 59.28739604015462
R&D to revenue (%): 24.276039756713725
SG&A to revenue (%): 40.324233987821216
Free cash flow (dilution-adjusted): -85387931.03448276
Retained earnings: -1066148132.1839081
Inventory turnover: 7.816826341236578
Receivables turnover: 8.78729398115037
Capitalized R&D asset: 77137500
ROCI (R&D-adjusted, %): -14.598592339800653
FCF margin (%): -26.87254329653713
Rule of 40 score: -26.87254329653713
Financial ratios for 8729.T — annual report dated 2022-03-31
Total revenue: 17303056875.92198
Capital expenditures: 0
Buffett classification: The Gruesome
Shares outstanding: 6708446123
COGS to revenue (%): 0
SG&A to revenue (%): 2.7792105314260898
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8729.T — annual report dated 2023-03-31
Total revenue: 15602057057.057058
Capital expenditures: 0
Buffett classification: The Gruesome
Shares outstanding: 6708446123
COGS to revenue (%): 0
SG&A to revenue (%): 3.0123751680545707
Capitalized R&D asset: 0
Revenue growth (%): -9.830631841891156
Rule of 40 score: -9.830631841891156
Financial ratios for 8729.T — annual report dated 2024-03-31
Total revenue: 21084581352.350765
Capital expenditures: 0
Buffett classification: The Gruesome
Shares outstanding: 6708446123
COGS to revenue (%): 0
SG&A to revenue (%): 2.1710283807107253
Capitalized R&D asset: 0
Revenue growth (%): 35.13975288799418
Rule of 40 score: 35.13975288799418
Financial ratios for 8729.T — annual report dated 2025-03-31
Total revenue: 16139185937.708862
Capital expenditures: 0
Buffett classification: The Gruesome
Shares outstanding: 6708446123
COGS to revenue (%): 0
SG&A to revenue (%): 2.815369738833707
Capitalized R&D asset: 0
Revenue growth (%): -23.45503252826279
Rule of 40 score: -23.45503252826279
Financial ratios for 9887.HK — annual report dated 2023-12-31
Total revenue: 1246835.4430379746
Gross profit: 798874.8241912798
Operating income: -36439662.447257385
Net income: -50949226.4416315
Capital expenditures: 1649507.7355836849
Operating cash flow: -27100562.58790436
Depreciation & amortization: 3362728.551336146
Net tangible assets: -133446554.14908579
Owner earnings: -49236005.62587904
Buffett classification: The Gruesome
Shares outstanding: 153278691
Book value: -133446554.14908579
Debt to equity: -0.07070789045167343
Current ratio: 0.26326164746039826
Quick ratio: 0.26326164746039826
Interest coverage ratio: -185.06142857142856
COGS to revenue (%): 35.9278059785674
R&D to revenue (%): 2604.1511562323744
SG&A to revenue (%): 67.46756909193458
Free cash flow (dilution-adjusted): -31258790.436005626
Retained earnings: -138221659.63431785
Capitalized R&D asset: 32469479.606188465
FCF margin (%): -2507.050197405528
Rule of 40 score: -2507.050197405528
Financial ratios for 9887.HK — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -36355205.47945206
Net income: -41262465.75342466
Capital expenditures: 407534.2465753425
Operating cash flow: -16276164.383561645
Depreciation & amortization: 3567397.2602739725
Net tangible assets: 36378082.19178082
Owner earnings: -38102602.73972603
Return on net tangible assets (%): -104.74054827534268
Buffett classification: The Gruesome
Shares outstanding: 153278691
Book value: 36378082.19178081
Debt to equity: 1.0034455490284684
Current ratio: 1.496994999196658
Quick ratio: 1.496994999196658
Interest coverage ratio: -46.04319916724497
Free cash flow (dilution-adjusted): -22428904.10958904
Retained earnings: -26789041.09589041
Capitalized R&D asset: 47190578.733406544
ROCI (R&D-adjusted, %): -35.837237910045246
Rosenberg metric: -0.024603869045040673
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for 9887.HK — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -10532093.663911846
Net income: -10381129.476584023
Capital expenditures: 52892.561983471074
Operating cash flow: -3631542.699724518
Depreciation & amortization: 803168.044077135
Net tangible assets: 26455234.159779616
Owner earnings: -9630853.994490359
Return on net tangible assets (%): -36.404342279957305
Buffett classification: The Gruesome
Shares outstanding: 153278691
Book value: 26537878.78787879
Debt to equity: 1.4321231152518619
Current ratio: 1.269764872797375
Quick ratio: 1.2297185188394184
Interest coverage ratio: -40.15913865546218
Free cash flow (dilution-adjusted): -3994352.61707989
Retained earnings: -37317768.59504132
Inventory turnover: 0
Capitalized R&D asset: 7954683.195592287
ROCI (R&D-adjusted, %): -14.32989703693358
Rule of 40 score: 0
Financial ratios for 9887.HK — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -12693165.969316596
Net income: -12695397.48953975
Capital expenditures: 0
Depreciation & amortization: 93305.43933054393
Net tangible assets: 14548814.50488145
Owner earnings: -12602092.050209206
Return on net tangible assets (%): -86.61937401140776
Buffett classification: The Gruesome
Shares outstanding: 153278691
Book value: 14626359.832635984
Debt to equity: 2.856442677193886
Current ratio: 1.0716176032435023
Quick ratio: 1.0116178758721683
Interest coverage ratio: -52.66782407407407
Inventory turnover: 0
Capitalized R&D asset: 15658786.973961756
ROCI (R&D-adjusted, %): -26.439260559462667
Rule of 40 score: 0
Financial ratios for ARTV — annual report dated 2022-12-31
Total revenue: 4931000
Operating income: -59829000
Net income: -60976000
Capital expenditures: 6299000
Operating cash flow: -50829000
Depreciation & amortization: 1158000
Net tangible assets: -140696000
Owner earnings: -66117000
Buffett classification: The Gruesome
Shares outstanding: 48588198
Book value: -140696000
Debt to equity: -0.1382270995621766
Current ratio: 4.084878048780488
Quick ratio: 4.084878048780488
COGS to revenue (%): 0
R&D to revenue (%): 891.9894544717096
SG&A to revenue (%): 421.33441492597854
Free cash flow (dilution-adjusted): -63712000
Retained earnings: -152591000
Receivables turnover: 9.392380952380952
Capitalized R&D asset: 43984000
ROCI (R&D-adjusted, %): -20.14776362223411
FCF margin (%): -1292.0705739200973
Rule of 40 score: -1292.0705739200973
Financial ratios for ARTV — annual report dated 2023-12-31
Total revenue: 2407418.06
Operating income: -30671000
Net income: -32766000
Capital expenditures: 3258000
Operating cash flow: -47430000
Depreciation & amortization: 2266000
Net tangible assets: -162015000
Owner earnings: -33758000
Buffett classification: The Gruesome
Shares outstanding: 48588198
Book value: -162015000
Debt to equity: -0.1043853964139123
Current ratio: 6.528257135846896
Quick ratio: 6.528257135846896
COGS to revenue (%): 0
R&D to revenue (%): 2087.33999445032
SG&A to revenue (%): 577.8805198462289
Free cash flow (dilution-adjusted): -57741000
Retained earnings: -181311000
Receivables turnover: 1.3694073151308306
Capitalized R&D asset: 79720280
ROCI (R&D-adjusted, %): -6.85467418678208
FCF margin (%): -2398.4616946838055
Revenue growth (%): -51.17789373352261
Rule of 40 score: -2449.639588417328
Financial ratios for AU.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -69001.47058823529
Operating income: -3309575.7352941176
Net income: -3466324.264705882
Capital expenditures: 70277.94117647059
Operating cash flow: -2008862.4999999998
Depreciation & amortization: 69001.47058823529
Net tangible assets: 45570608.82352941
Owner earnings: -3467600.735294117
Return on net tangible assets (%): -7.609292095969751
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 45570608.82352941
Debt to equity: 0.0003715307473399231
Current ratio: 9.642187678518475
Quick ratio: 9.642187678518475
Interest coverage ratio: -1849.2288414133116
Free cash flow (dilution-adjusted): -3396878.676470588
Retained earnings: -28375460.294117644
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.139528839187068
Rule of 40 score: 0
Financial ratios for AU.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -64953.78787878787
Operating income: -3137444.696969697
Net income: -4568600
Capital expenditures: 656896.9696969696
Operating cash flow: -1864373.4848484849
Depreciation & amortization: 64953.78787878787
Net tangible assets: 48753021.21212121
Owner earnings: -5160543.181818182
Return on net tangible assets (%): -10.585073608802611
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 48753021.21212121
Debt to equity: 0.00011052928064069625
Current ratio: 2.9381167949150475
Quick ratio: 2.9381167949150475
Interest coverage ratio: -2627.809010152284
Free cash flow (dilution-adjusted): -3756718.1818181816
Retained earnings: -33803922.72727273
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.435385169913635
Rule of 40 score: 0
Financial ratios for AU.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -14023.076923076924
Operating income: -360623.7762237762
Net income: -720933.5664335665
Capital expenditures: 0
Operating cash flow: -492521.67832167837
Depreciation & amortization: 14023.076923076924
Net tangible assets: 48569582.51748252
Owner earnings: -706910.4895104896
Return on net tangible assets (%): -1.455459266622353
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 48569582.51748252
Debt to equity: 0.000978899813018603
Current ratio: 3.103619863851734
Quick ratio: 3.103619863851734
Interest coverage ratio: -259.6636455186304
Free cash flow (dilution-adjusted): -372934.9650349651
Retained earnings: -34163560.13986014
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7418922556914282
Rule of 40 score: 0
Financial ratios for AU.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -60601.39860139861
Operating income: -2412321.6783216787
Net income: -2959939.160839161
Capital expenditures: 0
Operating cash flow: -1917832.1678321678
Depreciation & amortization: 60601.39860139861
Net tangible assets: 48569582.51748252
Owner earnings: -2899337.762237762
Return on net tangible assets (%): -5.969451685515624
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 48569582.51748252
Debt to equity: 0.000978899813018603
Current ratio: 3.103619863851734
Quick ratio: 3.103619863851734
Interest coverage ratio: -663.6437091188919
Free cash flow (dilution-adjusted): -2584345.4545454546
Retained earnings: -34163560.13986014
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.962742030278277
Rule of 40 score: 0
Financial ratios for AU.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -9800
Operating income: -795183.9160839161
Net income: -872488.8111888112
Capital expenditures: 7785.314685314685
Operating cash flow: 126858.74125874127
Depreciation & amortization: 9800
Net tangible assets: 48223061.53846154
Owner earnings: -870474.1258741259
Return on net tangible assets (%): -1.8050992577065161
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 48223061.53846154
Debt to equity: 0.0009419658162567316
Current ratio: 2.059582296556501
Quick ratio: 2.059582296556501
Interest coverage ratio: -605.8140649973361
Free cash flow (dilution-adjusted): -273316.0839160839
Retained earnings: -35036048.951048955
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6477446515640248
Rule of 40 score: 0
Financial ratios for AU.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -12902.189781021896
Operating income: -609031.3868613138
Net income: -592658.3941605838
Capital expenditures: 17575.912408759123
Operating cash flow: -766789.0510948905
Depreciation & amortization: 12902.919708029196
Net tangible assets: 50287532.84671532
Owner earnings: -597331.3868613137
Return on net tangible assets (%): -1.1878319596272064
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 50287532.84671532
Debt to equity: 0.0008988456455954314
Current ratio: 1.4674381465402657
Quick ratio: 1.4674381465402657
Interest coverage ratio: -444.7617270788912
Free cash flow (dilution-adjusted): -948124.8175182481
Retained earnings: -37163133.576642334
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2101169690444702
Rule of 40 score: 0
Financial ratios for AU.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -12530.935251798563
Operating income: -2026374.1007194247
Net income: -1888616.54676259
Capital expenditures: 0
Operating cash flow: -486806.4748201439
Depreciation & amortization: 12530.935251798563
Net tangible assets: 55196292.08633094
Owner earnings: -1876085.6115107916
Return on net tangible assets (%): -3.3989341323443605
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 55196291.36690648
Debt to equity: 0.000767594058849095
Current ratio: 2.404779627278543
Quick ratio: 2.404779627278543
Interest coverage ratio: -1500.6180074587107
Free cash flow (dilution-adjusted): -1779927.3381294967
Retained earnings: -38517028.05755396
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.6690322558458637
Rule of 40 score: 0
Financial ratios for AU.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -49268.61313868613
Operating income: -6034918.9781021895
Net income: -6134506.569343065
Capital expenditures: 25701.459854014596
Operating cash flow: -2140041.605839416
Depreciation & amortization: 49268.61313868613
Net tangible assets: 53352959.12408759
Owner earnings: -6110939.416058393
Return on net tangible assets (%): -11.453796596071932
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 53352959.12408759
Debt to equity: 0.0007642260766250332
Current ratio: 1.4611495971869395
Quick ratio: 1.4611495971869395
Interest coverage ratio: -1101.4973354649615
Free cash flow (dilution-adjusted): -6065947.445255474
Retained earnings: -41794281.02189781
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.304785059486711
Rule of 40 score: 0
Financial ratios for AU.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -13422.627737226276
Operating income: -2539921.897810219
Net income: -2714960.5839416054
Capital expenditures: 0.7299270072992701
Operating cash flow: -1011754.01459854
Depreciation & amortization: 13422.627737226276
Net tangible assets: 53352959.12408759
Owner earnings: -2701538.686131386
Return on net tangible assets (%): -5.063521743654713
Buffett classification: The Gruesome
Shares outstanding: 168728838
Book value: 53352959.12408759
Debt to equity: 0.0007642260766250332
Current ratio: 1.4611495971869395
Quick ratio: 1.4611495971869395
Interest coverage ratio: -1854.847014925373
Free cash flow (dilution-adjusted): -3026624.8175182478
Retained earnings: -41794281.02189781
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.757855279717045
Rule of 40 score: 0
Financial ratios for F3C.DE — annual report dated 2021-12-31
Total revenue: 73091248.86363636
Gross profit: 25725232.954545453
Operating income: -6176711.363636363
Net income: -6624384.090909091
Capital expenditures: 1149965.9090909092
Operating cash flow: 1225379.5454545454
Depreciation & amortization: 4895986.363636363
Net tangible assets: 36727938.63636363
Owner earnings: -2878363.6363636367
Return on net tangible assets (%): -7.836986618992616
Buffett classification: The Gruesome
Shares outstanding: 17397975
Book value: 56839606.81818182
Debt to equity: 0.18963953072575393
Current ratio: 2.796643104778285
Quick ratio: 2.1211255301329635
Interest coverage ratio: -13.272514168646573
COGS to revenue (%): 64.80394937218809
R&D to revenue (%): 5.0640824912831945
SG&A to revenue (%): 8.2781766919336
Free cash flow (dilution-adjusted): -10697767.045454545
Retained earnings: -94841896.5909091
Inventory turnover: 2.9385578285543392
Receivables turnover: 3.6528989213150944
Capitalized R&D asset: 3701401.1363636362
ROCI (R&D-adjusted, %): -4.688033808893823
FCF margin (%): -14.636180407059365
Rule of 40 score: -14.636180407059365
Financial ratios for F3C.DE — annual report dated 2022-12-31
Total revenue: 90669447.87234043
Gross profit: 33410715.95744681
Operating income: 4360838.29787234
Net income: 1135217.0212765958
Capital expenditures: 2283058.510638298
Operating cash flow: -5065422.340425532
Depreciation & amortization: 5311842.55319149
Net tangible assets: 90277488.29787235
Owner earnings: 4164001.0638297875
Return on net tangible assets (%): 4.612446737652452
Capex to operating income (%): 52.35366126169379
Buffett classification: The Good
Shares outstanding: 17397975
Book value: 110039487.23404256
Debt to equity: 0.14130243845347662
Current ratio: 4.1439824040966275
Quick ratio: 3.2312390866151564
Effective tax rate (%): 64.31158335777546
Interest coverage ratio: 6.727126521288188
COGS to revenue (%): 63.151075978219275
R&D to revenue (%): 5.210938010846297
SG&A to revenue (%): 8.517308740408124
Free cash flow (dilution-adjusted): -10083288.29787234
Retained earnings: -87652941.4893617
Inventory turnover: 2.1597354606141823
Receivables turnover: 4.706115749226795
Capitalized R&D asset: 7204667.4847678915
ROCI (R&D-adjusted, %): 4.733241539532563
Rosenberg metric: 2.0763712766489824
FCF margin (%): -11.120932722640239
Revenue growth (%): 24.04966296512331
Rule of 40 score: 12.928730242483072
Financial ratios for F3C.DE — annual report dated 2023-12-31
Total revenue: 131275601.1111111
Gross profit: 51993331.11111111
Operating income: 10999021.11111111
Net income: 23427213.333333332
Capital expenditures: 2454633.3333333335
Operating cash flow: 3973277.7777777775
Depreciation & amortization: 6068525.555555555
Net tangible assets: 120380486.66666666
Owner earnings: 27041105.555555556
Return on net tangible assets (%): 22.463030599329876
Capex to operating income (%): 22.316834457692654
Buffett classification: The Great
Shares outstanding: 17397975
Book value: 142370240
Debt to equity: 0.12763524955152925
Current ratio: 3.6112410236971475
Quick ratio: 2.865417953243024
Effective tax rate (%): -125.41918876302593
Interest coverage ratio: 12.382721439025305
COGS to revenue (%): 60.393758877474745
R&D to revenue (%): 4.482749739371473
SG&A to revenue (%): 9.430845323960979
Free cash flow (dilution-adjusted): -3243185.5555555555
Retained earnings: -68121413.33333333
Inventory turnover: 2.849221511805111
Receivables turnover: 4.1245386610432835
Capitalized R&D asset: 10271787.28634752
ROCI (R&D-adjusted, %): 7.16935625823889
Rosenberg metric: 3.9330544125452307
FCF margin (%): -2.470516629217746
Revenue growth (%): 44.78482464781609
Rule of 40 score: 42.31430801859834
Financial ratios for F3C.DE — quarterly report dated 2024-09-30
Total revenue: 38148290
Gross profit: 16002836.666666666
Operating income: 3914572.222222222
Net income: 2612974.4444444445
Capital expenditures: 941413.3333333333
Operating cash flow: -2073424.4444444445
Depreciation & amortization: 1731107.7777777778
Net tangible assets: 130996707.77777778
Owner earnings: 3402668.888888889
Return on net tangible assets (%): 2.597522446641301
Capex to operating income (%): 24.048945322534177
Buffett classification: The Great
Shares outstanding: 17397975
Book value: 153427810
Debt to equity: 0.1315266914272075
Current ratio: 3.554999296136519
Quick ratio: 2.8129883749579743
Effective tax rate (%): 29.4195491731139
Interest coverage ratio: 10.532512802728856
COGS to revenue (%): 58.050972490073164
R&D to revenue (%): 4.299246149405095
SG&A to revenue (%): 60.82743595234981
Free cash flow (dilution-adjusted): -4586570
Retained earnings: -58390908.88888889
Inventory turnover: 0.7214746167978715
Receivables turnover: 1.1451117578782035
Capitalized R&D asset: 1640088.8888888888
ROCI (R&D-adjusted, %): 2.901453749350856
FCF margin (%): -12.023002865921383
Rule of 40 score: -12.023002865921383
Financial ratios for F3C.DE — annual report dated 2024-12-31
Total revenue: 150712922.9166667
Gross profit: 61778418.75
Operating income: 14860929.166666668
Net income: 9166813.541666668
Capital expenditures: 6161896.875
Operating cash flow: 15061994.791666668
Depreciation & amortization: 6721145.833333334
Net tangible assets: 123314407.29166667
Owner earnings: 9726062.500000002
Return on net tangible assets (%): 7.88720694816758
Capex to operating income (%): 41.463738948579646
Buffett classification: The Good
Shares outstanding: 17397975
Book value: 144821633.33333334
Debt to equity: 0.13049467574941037
Current ratio: 3.4266821013788866
Quick ratio: 2.6546575753173407
Effective tax rate (%): 34.40310295574944
Interest coverage ratio: 16.21197799537953
COGS to revenue (%): 59.00920932695401
R&D to revenue (%): 5.02409292125096
SG&A to revenue (%): 9.973797037947545
Free cash flow (dilution-adjusted): 3404439.583333334
Retained earnings: -56998861.458333336
Inventory turnover: 2.7906995383227304
Receivables turnover: 4.036585787404456
Capitalized R&D asset: 13073904.73705674
ROCI (R&D-adjusted, %): 9.39100288408103
Rosenberg metric: 1.6627854290586166
FCF margin (%): 2.2588902911900544
Revenue growth (%): 14.806499944421445
Rule of 40 score: 17.0653902356115
Financial ratios for F3C.DE — quarterly report dated 2024-12-31
Total revenue: 41212537.5
Gross profit: 16019751.041666668
Operating income: 2919729.166666667
Net income: 665061.4583333334
Capital expenditures: 776925
Operating cash flow: 370114.5833333334
Depreciation & amortization: 2006440.625
Net tangible assets: 123511117.70833334
Owner earnings: 1894577.0833333335
Return on net tangible assets (%): 1.5339324252633701
Capex to operating income (%): 26.609488608389757
Buffett classification: The Good
Shares outstanding: 17397975
Book value: 145018343.75
Debt to equity: 0.13031766599067462
Current ratio: 3.462754583162114
Quick ratio: 2.6807895509759567
Effective tax rate (%): 68.86510661847048
Interest coverage ratio: 12.236653118601597
COGS to revenue (%): 61.12893790714375
R&D to revenue (%): 6.090756261570483
SG&A to revenue (%): -11.975471865408274
Free cash flow (dilution-adjusted): -1116733.3333333335
Retained earnings: -54076415.625
Inventory turnover: 0.7905311689440443
Receivables turnover: 1.103806760003965
Capitalized R&D asset: 3609014.763888889
ROCI (R&D-adjusted, %): 2.4513181200503262
Rosenberg metric: 0.010313084317924284
FCF margin (%): -2.709693217345167
Revenue growth (%): 8.032463578315044
Rule of 40 score: 5.322770360969876
Financial ratios for F3C.DE — quarterly report dated 2025-03-31
Total revenue: 41977768.47826087
Gross profit: 18616430.43478261
Operating income: 3370148.913043478
Net income: 2515942.3913043477
Capital expenditures: 539175
Operating cash flow: 2231547.8260869565
Depreciation & amortization: 1958806.5217391304
Net tangible assets: 131368745.6521739
Owner earnings: 3935573.9130434785
Return on net tangible assets (%): 2.995822098708113
Capex to operating income (%): 15.998551218708243
Buffett classification: The Great
Shares outstanding: 17397975
Book value: 153523529.3478261
Debt to equity: 0.12741017527217025
Current ratio: 3.4450774708954537
Quick ratio: 2.667712975748171
Effective tax rate (%): 17.527916287785054
Interest coverage ratio: 9.814528050444268
COGS to revenue (%): 55.6516910982928
R&D to revenue (%): 5.432073038039519
SG&A to revenue (%): 28.88767959914185
Free cash flow (dilution-adjusted): -765272.8260869564
Retained earnings: -53911621.73913043
Inventory turnover: 0.6880449434288703
Receivables turnover: 1.0011178589285517
Capitalized R&D asset: 4503296.366394928
ROCI (R&D-adjusted, %): 2.0114074946135094
Rosenberg metric: 1.0344696553007402
FCF margin (%): -1.823043134089584
Revenue growth (%): 1.8567917063123507
Rule of 40 score: 0.033748572222766615
Financial ratios for F3C.DE — quarterly report dated 2025-06-30
Total revenue: 41161342.35294118
Gross profit: 16638515.294117648
Operating income: -4291945.882352942
Net income: -2279009.411764706
Capital expenditures: 401660
Operating cash flow: -9821251.764705883
Depreciation & amortization: 2447195.294117647
Net tangible assets: 140429627.05882353
Owner earnings: -233474.1176470588
Return on net tangible assets (%): -0.16625702320583716
Buffett classification: The Gruesome
Shares outstanding: 17397975
Book value: 163407276.4705882
Debt to equity: 0.126729060269006
Current ratio: 3.3352609755407516
Quick ratio: 2.4486747171419054
Interest coverage ratio: -20.511610385813402
COGS to revenue (%): 59.57732585237531
R&D to revenue (%): 7.3983381494361025
SG&A to revenue (%): -0.5124254079520244
Free cash flow (dilution-adjusted): -12443715.294117648
Retained earnings: -63734497.64705882
Inventory turnover: 0.5690053926713718
Receivables turnover: 0.8418165330012309
Capitalized R&D asset: 5401382.751998082
ROCI (R&D-adjusted, %): -2.076494215491102
Rosenberg metric: -0.8674065679930921
FCF margin (%): -30.231558503165495
Revenue growth (%): -1.9449012058430266
Rule of 40 score: -32.17645970900852
Financial ratios for F3C.DE — quarterly report dated 2025-09-30
Total revenue: 34237757.64705882
Gross profit: 12035231.764705883
Operating income: -269576.4705882353
Net income: -1580770.5882352942
Capital expenditures: 778263.5294117647
Operating cash flow: -7173097.647058824
Depreciation & amortization: 2235103.529411765
Net tangible assets: 139465589.4117647
Owner earnings: -123930.5882352941
Return on net tangible assets (%): -0.08886105078536301
Buffett classification: The Gruesome
Shares outstanding: 17397975
Book value: 161966882.3529412
Debt to equity: 0.11797705921726193
Current ratio: 3.6387259969180485
Quick ratio: 2.541395100676638
Interest coverage ratio: -0.5430501244223249
COGS to revenue (%): 64.84807244454643
R&D to revenue (%): 7.734189161783342
SG&A to revenue (%): 81.72839040379706
Free cash flow (dilution-adjusted): -8095220
Retained earnings: -65338797.64705882
Inventory turnover: 0.47480246803781834
Receivables turnover: 0.6572804437565957
Capitalized R&D asset: 5440820.792583121
ROCI (R&D-adjusted, %): -0.15263127005576718
Rosenberg metric: -1.5116248343131282
FCF margin (%): -23.644130212760636
Revenue growth (%): -16.820599888399006
Rule of 40 score: -40.464730101159645
Financial ratios for F3C.DE — annual report dated 2025-12-31
Total revenue: 168558003.52941176
Gross profit: 68699205.88235295
Operating income: 9474144.705882354
Net income: -713630.5882352941
Capital expenditures: 2954895.294117647
Operating cash flow: -5811056.470588235
Depreciation & amortization: 9104016.470588235
Net tangible assets: 141011262.3529412
Owner earnings: 5435490.5882352935
Capex to operating income (%): 31.189045405681814
Buffett classification: The Good
Shares outstanding: 17397975
Book value: 162999043.52941176
Debt to equity: 0.12001714596852886
Current ratio: 3.369315228771699
Quick ratio: 2.5101355616594967
Effective tax rate (%): 124.33210983088881
Interest coverage ratio: 6.904559928802556
COGS to revenue (%): 59.242987906910294
R&D to revenue (%): 6.390147994647721
SG&A to revenue (%): 10.678649750611594
Free cash flow (dilution-adjusted): -13517554.11764706
Retained earnings: -65088816.47058824
Inventory turnover: 2.405514944846442
Receivables turnover: 2.9910046467630855
Capitalized R&D asset: 17786286.967769608
ROCI (R&D-adjusted, %): 6.216739087681383
Rosenberg metric: 0.9140023993491927
FCF margin (%): -8.019526711639282
Revenue growth (%): 11.840444911689564
Rule of 40 score: 3.820918200050283
Financial ratios for F3C.DE — quarterly report dated 2025-12-31
Total revenue: 47724142.35294118
Gross profit: 19875910.588235296
Operating income: 10387976.470588235
Net income: 472192.9411764706
Capital expenditures: 1191394.1176470588
Operating cash flow: 8767970.588235294
Depreciation & amortization: 2301597.6470588236
Net tangible assets: 141011262.3529412
Owner earnings: 1582396.4705882357
Return on net tangible assets (%): 1.1221773666755848
Capex to operating income (%): 11.468972046868666
Buffett classification: The Great
Shares outstanding: 17397975
Book value: 162999043.52941176
Debt to equity: 0.12001714596852886
Current ratio: 3.369315228771699
Quick ratio: 2.5101355616594967
Effective tax rate (%): 89.77235286193107
Interest coverage ratio: 35.23272934763959
COGS to revenue (%): 58.35250334884149
R&D to revenue (%): 5.468486402528886
SG&A to revenue (%): -19.364210803554084
Free cash flow (dilution-adjusted): 7849676.470588236
Retained earnings: -65088816.47058824
Inventory turnover: 0.6708406197149968
Receivables turnover: 0.846848731899715
Capitalized R&D asset: 5388891.152941177
ROCI (R&D-adjusted, %): 5.579435253718126
Rosenberg metric: 2.96096695813198
FCF margin (%): 16.44801998228989
Revenue growth (%): 39.390385447865036
Rule of 40 score: 55.83840543015492
Financial ratios for GLIBA — annual report dated 2023-12-31
Total revenue: 904000000
Gross profit: 632000000
Operating income: 112000000
Net income: 41000000
Capital expenditures: 222000000
Operating cash flow: 276000000
Depreciation & amortization: 230000000
Net tangible assets: -314000000
Owner earnings: 49000000
Return on net tangible assets (%): -15.605095541401273
Capex to operating income (%): 198.21428571428572
Buffett classification: The Gruesome
Shares outstanding: 3650938
Book value: 1503000000
Debt to equity: 0.7345309381237525
Current ratio: 1.8470588235294119
Quick ratio: 1.8470588235294119
Effective tax rate (%): 36.92307692307693
Interest coverage ratio: 2.196078431372549
COGS to revenue (%): 30.08849557522124
SG&A to revenue (%): 12.721238938053098
Free cash flow (dilution-adjusted): 35000000
Retained earnings: -283000000
Receivables turnover: 5.349112426035503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.543182537171781
FCF margin (%): 3.8716814159292032
Rule of 40 score: 3.8716814159292032
Financial ratios for GLIBA — annual report dated 2024-12-31
Total revenue: 940000000
Gross profit: 661000000
Operating income: 140000000
Net income: 70000000
Capital expenditures: 247000000
Operating cash flow: 278000000
Depreciation & amortization: 259000000
Net tangible assets: -334000000
Owner earnings: 82000000
Return on net tangible assets (%): -24.550898203592812
Capex to operating income (%): 176.42857142857142
Buffett classification: The Gruesome
Shares outstanding: 3650938
Book value: 1429000000
Debt to equity: 0.7984604618614416
Current ratio: 1.6614583333333333
Quick ratio: 1.6614583333333333
Effective tax rate (%): 27.835051546391753
Interest coverage ratio: 2.857142857142857
COGS to revenue (%): 29.680851063829788
SG&A to revenue (%): 13.829787234042554
Free cash flow (dilution-adjusted): 18000000
Retained earnings: -363000000
Receivables turnover: 5.108695652173913
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.38871473354232
FCF margin (%): 1.9148936170212765
Revenue growth (%): 3.982300884955752
Rule of 40 score: 5.897194501977029
Financial ratios for GLIBA — quarterly report dated 2025-03-31
Total revenue: 242000000
Gross profit: 180000000
Operating income: 58000000
Net income: 35000000
Capital expenditures: 65000000
Operating cash flow: 119000000
Depreciation & amortization: 65000000
Net tangible assets: -288000000
Owner earnings: 35000000
Return on net tangible assets (%): -12.152777777777777
Capex to operating income (%): 112.06896551724137
Buffett classification: The Gruesome
Shares outstanding: 3650938
Book value: 1465000000
Debt to equity: 0.7808873720136519
Current ratio: 1.8159203980099503
Quick ratio: 1.8159203980099503
Effective tax rate (%): 28.57142857142857
Interest coverage ratio: 5.8
COGS to revenue (%): 25.6198347107438
SG&A to revenue (%): 12.396694214876034
Free cash flow (dilution-adjusted): 52000000
Retained earnings: -328000000
Receivables turnover: 1.4846625766871167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.795109873104302
FCF margin (%): 21.487603305785125
Rule of 40 score: 21.487603305785125